SFX by Ex Libris Inc.

Title:	Gain-of-function mutations of c-kit in human gastrointestinal stromal tumors
Source:	Science [0036-8075] Hirota, S yr:1998

Basic

Sorry, no full text available...

Please use the document delivery service (see below)

Holding information

Holdings in library search engine ALBERT

Document delivery

Request document via Library/Bibliothek

Users interested in this article also expressed an interest in the following:
description	1.	Heinrich, Michael C C. "PDGFRA activating mutations in gastrointestinal stromal tumors." Science 299.5607 (2003): 708-10.
description	2.	Hirota, S. "Gain-of-function mutations of platelet-derived growth factor receptor α gene in gastrointestinal stromal tumors." Gastroenterology 125.3 (2003): 660-667.
description	3.	Corless, Christopher L. "Gastrointestinal stromal tumours: origin and molecular oncology." Nature Reviews. Cancer 11.12 (2011): 865-878.
description	4.	Nishida, T. "Gastrointestinal stromal tumors (GIST): a model for molecule-based diagnosis and treatment of solid tumors." Cancer Science 94.4 (2003): 315-20.
description	5.	Hogendoorn, Pancras C W C. "Incidence of gastrointestinal stromal tumours is underestimated: results of a nation-wide study." European journal of cancer 41.18 (2006): 2868-72.
description	6.	Rubin, B P P. "KIT activation is a ubiquitous feature of gastrointestinal stromal tumors." Cancer research 61.22 (2001): 8118-21.
description	7.	Fletcher, Jonathan A A. "KIT mutations in GIST." Current opinion in genetics & development 17.1 (2007): 3-7.
description	8.	Colombo, C. "Adjuvant imatinib therapy for gastrointestinal stromal tumors." Journal of surgical oncology 104.8 (2011): 896-900.
description	9.	Matei, D. "Autocrine activation of PDGFRalpha promotes the progression of ovarian cancer." Oncogene 25.14 (2006): 2060-9.
description	10.	Lohmueller, CL E. "Meta-analysis of genetic association studies supports a contribution of common variants to susceptibility to common disease." Nature genetics 33.2 (2003): 177-182.
description	11.	Westermark, B. "Mechanism of action and in vivo role of platelet-derived growth factor." Physiological reviews 79.4 (1999): 1283-316.
description	12.	Pauls, K. "PDGFR [alpha]-and c-kit-mutated gastrointestinal stromal tumours (GISTs) are characterized by distinctive histological and immunohistochemical features." Histopathology 46.2 (2005): 166-175.
description	13.	Demetri, H D. "Effect of the tyrosine kinase inhibitor STI571 in a patient with a metastatic gastrointestinal stromal tumor." New England Journal of Medicine, The 344.14 (2001): 1052-6.
description	14.	Kim, Hyun Ju J. "Correlation of KIT and platelet-derived growth factor receptor alpha mutations with gene activation and expression profiles in gastrointestinal stromal tumors." Oncogene 24.6 (2005): 1066-74.
description	15.	Davis RP, Ng ES, Costa M, Mossman AK, Sourris K, E, Richard P. "Targeting a GFP reporter gene to the MIXL1 locus of human embryonic stem cells identifies human primitive streak-like cells and enables isolation of primitive hematopoietic precursors." Blood 111.4: 1876-1884.
description	16.	Lasota, J. "Gastrointestinal stromal tumors: review on morphology, molecular pathology, prognosis, and differential diagnosis." Archives of pathology & laboratory medicine 130.10 (2006): 1466-78.
description	17.	YANCEY,, M. F., M. F. F. "Pharmacokinetic properties of toceranib phosphate (Palladia™, SU11654), a novel tyrosine kinase inhibitor, in laboratory dogs and dogs with mast cell tumors." Journal of veterinary pharmacology and therapeutics 33.2 (2010): 162-171.
description	18.	Pastorelli, F. "Gastrointestinal stromal tumors: report of an audit and review of the literature." European journal of cancer prevention 18.2 (2009): 106-16.
description	19.	Schneider, L. "PDGFRalphaalpha signaling is regulated through the primary cilium in fibroblasts." Current biology 15.20: 1861-1866.
description	20.	Wozniak, A. "Array CGH analysis in primary gastrointestinal stromal tumors: Cytogenetic profile correlates with anatomic site and tumor aggressiveness, irrespective of mutational status." Genes, chromosomes & cancer 46.3 (2007): 261-76.